Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients.

Rosa M, Arlotti M, Marceglia S, Cogiamanian F, Ardolino G, Fonzo AD, Lopiano L, Scelzo E, Merola A, Locatelli M, Rampini PM, Priori A.

Mov Disord. 2017 Apr;32(4):628-629. doi: 10.1002/mds.26953. Epub 2017 Feb 17. No abstract available.

2.

Missed treatment in an Italian HBV infected patients cohort: HBV RER.

Cuomo G, Borghi V, Andreone P, Massari M, Villa E, Pietrangelo A, Verucchi G, Ferrari C; HBV-RER Group..

Dig Liver Dis. 2016 Nov;48(11):1346-1350. doi: 10.1016/j.dld.2016.07.016. Epub 2016 Jul 21.

PMID:
27498074
3.

Risk of Infection After Local Field Potential Recording from Externalized Deep Brain Stimulation Leads in Parkinson's Disease.

Rosa M, Scelzo E, Locatelli M, Carrabba G, Levi V, Arlotti M, Barbieri S, Rampini P, Priori A.

World Neurosurg. 2017 Jan;97:64-69. doi: 10.1016/j.wneu.2016.09.069. Epub 2016 Sep 28.

PMID:
27686508
4.

The adaptive deep brain stimulation challenge.

Arlotti M, Rosa M, Marceglia S, Barbieri S, Priori A.

Parkinsonism Relat Disord. 2016 Jul;28:12-7. doi: 10.1016/j.parkreldis.2016.03.020. Epub 2016 Apr 2. Review.

PMID:
27079257
5.

Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's Disease.

Marceglia S, Mrakic-Sposta S, Rosa M, Ferrucci R, Mameli F, Vergari M, Arlotti M, Ruggiero F, Scarpini E, Galimberti D, Barbieri S, Priori A.

Front Neurosci. 2016 Mar 31;10:134. doi: 10.3389/fnins.2016.00134. eCollection 2016.

6.

An external portable device for adaptive deep brain stimulation (aDBS) clinical research in advanced Parkinson's Disease.

Arlotti M, Rossi L, Rosa M, Marceglia S, Priori A.

Med Eng Phys. 2016 May;38(5):498-505. doi: 10.1016/j.medengphy.2016.02.007. Epub 2016 Mar 27.

PMID:
27029510
7.

Electromyography data in chronic migraine patients by using neurostimulation with the Cefaly® device.

Didier HA, Di Fiore P, Marchetti C, Tullo V, Frediani F, Arlotti M, Giannì AB, Bussone G.

Neurol Sci. 2015 May;36 Suppl 1:115-9. doi: 10.1007/s10072-015-2154-9.

PMID:
26017525
8.

Adaptive deep brain stimulation in a freely moving Parkinsonian patient.

Rosa M, Arlotti M, Ardolino G, Cogiamanian F, Marceglia S, Di Fonzo A, Cortese F, Rampini PM, Priori A.

Mov Disord. 2015 Jun;30(7):1003-5. doi: 10.1002/mds.26241. Epub 2015 May 21. No abstract available.

9.

Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy.

Camoni L, Raimondo M, Dorrucci M, Regine V, Salfa MC, Suligoi B; CARPHA Study Group..

AIDS Res Hum Retroviruses. 2015 Mar;31(3):282-7. doi: 10.1089/AID.2014.0154. Epub 2015 Jan 6.

10.

Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.

Gagliotti C, Cappelli V, Carretto E, Marchi M, Pan A, Ragni P, Sarti M, Suzzi R, Tura GA, Moro ML; Emilia-Romagna Group for CPE Control..

Euro Surveill. 2014 Oct 30;19(43). pii: 20943.

11.

Abnormal local field potentials precede clinical complications after DBS surgery for Parkinson's disease: a case report.

Cortese F, Rosa M, Arlotti M, Cogiamanian F, Ardolino G, Rampini P, Carrabba G, Locatelli M, Levi V, Priori A.

Clin Neurophysiol. 2015 May;126(5):1056-8. doi: 10.1016/j.clinph.2014.08.013. Epub 2014 Sep 6. No abstract available.

PMID:
25277404
12.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group..

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.

PMID:
25042234
13.

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.

Marchetti G, Cozzi-Lepri A, Tincati C, Calcagno A, Ceccherini-Silberstein F, De Luca A, Antinori A, Castagna A, Puoti M, Monforte Ad; Icona Foundation Study Group..

BMC Infect Dis. 2014 Feb 12;14:79. doi: 10.1186/1471-2334-14-79.

14.

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.

Lapadula G, Cozzi-Lepri A, Marchetti G, Antinori A, Chiodera A, Nicastri E, Parruti G, Galli M, Gori A, Monforte Ad; ICONA Foundation Study..

AIDS. 2013 Mar 13;27(5):769-79. doi: 10.1097/QAD.0b013e32835cb747.

PMID:
23719349
15.

Cellular effects of acute direct current stimulation: somatic and synaptic terminal effects.

Rahman A, Reato D, Arlotti M, Gasca F, Datta A, Parra LC, Bikson M.

J Physiol. 2013 May 15;591(10):2563-78. doi: 10.1113/jphysiol.2012.247171. Epub 2013 Mar 11.

16.

Axon terminal polarization induced by weak uniform DC electric fields: a modeling study.

Arlotti M, Rahman A, Minhas P, Bikson M.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:4575-8. doi: 10.1109/EMBC.2012.6346985.

PMID:
23366946
17.

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG; D:A:D Study Group..

J Int AIDS Soc. 2012 Oct 10;15(2):17426. doi: 10.7448/IAS.15.2.17426.

18.

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis.

Girardi E, Scognamiglio P, Angeletti C, Gori A, Buonfrate D, Arlotti M, Mazzarello G, Castagna A, Andreoni M, d'Arminio Monforte A, Antinori A, Ippolito G; I.Co.Na Foundation Study..

BMC Health Serv Res. 2012 Feb 15;12:38. doi: 10.1186/1472-6963-12-38.

19.

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.

Nozza S, Canducci F, Galli L, Cozzi-Lepri A, Capobianchi MR, Ceresola ER, Narciso P, Libertone R, Castelli P, Moioli M, D'Arminio Monforte A, Castagna A; ICONA Foundation..

J Antimicrob Chemother. 2012 May;67(5):1224-7. doi: 10.1093/jac/dkr600. Epub 2012 Jan 31.

PMID:
22298348
20.

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.

Vescini F, Cozzi-Lepri A, Borderi M, Re MC, Maggiolo F, De Luca A, Cassola G, Vullo V, Carosi G, Antinori A, Tozzi V, Monforte AD; Icona Foundation Study Group..

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):163-72. doi: 10.1097/QAI.0b013e31822e57e9.

PMID:
21826011

Supplemental Content

Loading ...
Support Center